Similar articles

• BFM group treatment results in relapsed childhood acute lymphoblastic leukemia.

  Henze G, Fengler R, Hartmann R, Niethammer D, Schellong G, Riehm H. Henze G, et al. Haematol Blood Transfus. 1990;33:619-26. doi: 10.1007/978-3-642-74643-7_113. Haematol Blood Transfus. 1990. PMID: 2182452 Clinical Trial. No abstract available.
• Results of acute lymphoblastic leukemia therapy in childhood: GDR-experiences 1981-1987.

  Zintl F, Malke H, Reimann M, Dörffel W, Domula M, Eggers G, Exadaktylos P, Kotte W, Krause I, Kunert W, et al. Zintl F, et al. Haematol Blood Transfus. 1990;33:478-82. doi: 10.1007/978-3-642-74643-7_86. Haematol Blood Transfus. 1990. PMID: 2182440 Clinical Trial. No abstract available.
• Results and significance of six randomized trials in four consecutive ALL-BFM studies.

  Riehm H, Gadner H, Henze G, Kornhuber B, Lampert F, Niethammer D, Reiter A, Schellong G. Riehm H, et al. Haematol Blood Transfus. 1990;33:439-50. doi: 10.1007/978-3-642-74643-7_81. Haematol Blood Transfus. 1990. PMID: 2182435 Review. No abstract available.
• Risk of CNS relapse after systemic relapse of childhood acute lymphoblastic leukemia.

  Fengler R, Hartmann R, Bode U, Janka G, Jürgens H, Riehm H, Henze G. Fengler R, et al. Haematol Blood Transfus. 1990;33:511-5. doi: 10.1007/978-3-642-74643-7_92. Haematol Blood Transfus. 1990. PMID: 2182445 Clinical Trial. No abstract available.
• More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trials.

  Sallan SE, Gelber RD, Kimball V, Donnelly M, Cohen HJ. Sallan SE, et al. Haematol Blood Transfus. 1990;33:459-66. doi: 10.1007/978-3-642-74643-7_83. Haematol Blood Transfus. 1990. PMID: 2182437 Review.